{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:30:54Z","timestamp":1786998654059,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.vph.2026.107612","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:37:51Z","timestamp":1777588671000},"page":"107612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clinical characteristics and five-year outcomes in a prospective Russian real-world heart failure cohort"],"prefix":"10.1016","volume":"163","author":[{"given":"Nana","family":"Pogosova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatevik","family":"Terteryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashot","family":"Avagimyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Arutyunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Popova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya","family":"Vorobyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Osipova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radima","family":"Zhetisheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aza","family":"Ausheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinda","family":"Madonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vph.2026.107612_bb0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40364-025-00728-8","article-title":"Global, regional, and national burden of heart failure and its underlying causes, 1990-2021: results from the global burden of disease study 2021","volume":"13","author":"Ran","year":"2025","journal-title":"Biomark. Res."},{"issue":"31","key":"10.1016\/j.vph.2026.107612_bb0010","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1093\/eurheartj\/ehaf323","article-title":"Heart failure: assessment of the global economic burden","volume":"46","author":"Darvish","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2026.107612_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.70068","article-title":"Rising burden of heart failure: an urgent global public health concern","author":"Bozkurt","year":"2025","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.vph.2026.107612_bb0020","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41569-024-01098-8","article-title":"Trials and tribulations of cell therapy for heart failure: an update on ongoing trials","volume":"22","author":"Zhang","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"10.1016\/j.vph.2026.107612_bb0025","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cardfail.2025.01.022","article-title":"Efficacy of GLP-1 receptor agonists in patients with heart failure and mildly reduced or preserved ejection fraction: a systematic review and meta-analysis","volume":"31","author":"Waqas","year":"2025","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.vph.2026.107612_bb0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.35401\/2541-9897-2024-9-4-126-135","article-title":"Protective potential of sodium-glucose cotransporter 2 inhibitors in internal medicine (Part 1)","volume":"4","author":"Avagimyan","year":"2024","journal-title":"Innov. Med. Kuban"},{"issue":"15","key":"10.1016\/j.vph.2026.107612_bb0035","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2023.12.024","article-title":"2024 ACC expert consensus decision pathway for treatment of heart failure with reduced ejection fraction: a report of the American College of Cardiology Solution set Oversight Committee","volume":"83","author":"Maddox","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"issue":"37","key":"10.1016\/j.vph.2026.107612_bb0040","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"ESC Scientific Document Group. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.vph.2026.107612_bb0045","doi-asserted-by":"crossref","DOI":"10.15829\/1560-4071-2023-5452","article-title":"Cardiovascular prevention 2022. Russian national guidelines","volume":"28","author":"Boytsov","year":"2023","journal-title":"Russ. J. Cardiol."},{"issue":"1","key":"10.1016\/j.vph.2026.107612_bb0050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","article-title":"WRITING COMMITTEE MEMBERS. HF STATS 2024: heart failure epidemiology and outcomes statistics an updated 2024 report from the Heart Failure Society of America","volume":"31","author":"Bozkurt","year":"2025","journal-title":"J. Card. Fail."},{"issue":"1","key":"10.1016\/j.vph.2026.107612_bb0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.18087\/cardio.2024.1.n2636","article-title":"Preventive cardiology 2024: state of problem perspectives of development","volume":"64","author":"Pogosova","year":"2024","journal-title":"Kardiologiia"},{"key":"10.1016\/j.vph.2026.107612_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2023.100609","article-title":"Preventing new-onset heart failure: intervening at stage A","volume":"16","author":"Upadhya","year":"2023","journal-title":"Am. J. Prev. Cardiol."},{"issue":"5","key":"10.1016\/j.vph.2026.107612_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2025.103023","article-title":"Identifying low-risk in patients with worsening heart failure with short hospital stay: a comparison of risk scores in predicting 30-day risk events","volume":"50","author":"Burgos","year":"2025","journal-title":"Curr. Probl. Cardiol."},{"issue":"9403","key":"10.1016\/j.vph.2026.107612_bb0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"WHO Expert Consultation","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vph.2026.107612_bb0075","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.36660\/abc.20220196","article-title":"NYHA classification and cardiopulmonary exercise test variables in patients with heart failure","volume":"118","author":"Costa","year":"2022","journal-title":"Arq. Bras. Cardiol."},{"issue":"14","key":"10.1016\/j.vph.2026.107612_bb0080","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/heartjnl-2016-310828","article-title":"Physical activity in adults with congenital heart disease and associations with functional outcomes","volume":"103","author":"M\u00fcller","year":"2017","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.vph.2026.107612_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/2150131916659282","article-title":"Timed up and go (TUG) test: normative reference values for ages 20 to 59 years and relationships with physical and mental health risk factors","volume":"8","author":"Kear","year":"2017","journal-title":"J. Prim. Care Community Health"},{"issue":"1","key":"10.1016\/j.vph.2026.107612_bb0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pec.2013.09.014","article-title":"The European heart failure self-care behavior scale: new insights into factorial structure, reliability, precision and scoring procedure","volume":"94","author":"Vellone","year":"2014","journal-title":"Patient Educ. Couns."},{"issue":"5","key":"10.1016\/j.vph.2026.107612_bb0095","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cardfail.2024.09.010","article-title":"The psychometric performance of the Kansas City cardiomyopathy Questionnaire-12 in symptomatic obstructive hypertrophic cardiomyopathy","volume":"31","author":"Sauer","year":"2025","journal-title":"J. Card. Fail."},{"issue":"5","key":"10.1016\/j.vph.2026.107612_bb0100","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/occmed\/kqv203","article-title":"The brief illness perception questionnaire","volume":"66","author":"Basu","year":"2016","journal-title":"Occup. Med. (Lond.)"},{"issue":"4","key":"10.1016\/j.vph.2026.107612_bb0105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.genhosppsych.2005.03.002","article-title":"Using the hospital anxiety and depression scale to screen for depression in cardiac patients","volume":"27","author":"Bambauer","year":"2005","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"1","key":"10.1016\/j.vph.2026.107612_bb0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/arclin\/acab029","article-title":"Performances on the Montreal cognitive assessment along the cardiovascular disease continuum","volume":"37","author":"Gagnon","year":"2022","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"5","key":"10.1016\/j.vph.2026.107612_bb0115","first-page":"0","article-title":"Inflammatory mechanisms in heart failure with preserved ejection fraction","volume":"38","author":"Daou","year":"2023","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.vph.2026.107612_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132663","article-title":"Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine","volume":"418","author":"Avagimyan","year":"2025","journal-title":"Int. J. Cardiol."},{"issue":"1 Pt A","key":"10.1016\/j.vph.2026.107612_bb0125","article-title":"Diabetic cardiomyopathy: 2023 update by the international multidisciplinary board of experts","volume":"49","author":"Avagimyan","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"issue":"7","key":"10.1016\/j.vph.2026.107612_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.100858","article-title":"Social vulnerability index and cardiovascular disease care continuum: a scoping review","volume":"3","author":"Ibrahim","year":"2024","journal-title":"JACC Adv."},{"issue":"1","key":"10.1016\/j.vph.2026.107612_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0296527","article-title":"Comorbidities in heart failure patients that predict cardiovascular readmissions within 100 days-an observational study","volume":"19","author":"Scholten","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vph.2026.107612_bb0140","article-title":"The neurohormonal overactivity syndrome in heart failure","volume":"13","author":"Xanthopoulos","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.vph.2026.107612_bb0145","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2021.33","article-title":"Management of Heart Failure in patients with chronic kidney disease","volume":"17","author":"Ryan","year":"2022","journal-title":"Eur. Cardiol."},{"issue":"10","key":"10.1016\/j.vph.2026.107612_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2025.103146","article-title":"Metabolic syndrome, ischemic heart disease, and heart failure: insights from the Colombian heart failure registry (RECOLFACA)","author":"Mej\u00eda","year":"2025","journal-title":"Curr. Probl. Cardiol."},{"issue":"20","key":"10.1016\/j.vph.2026.107612_bb0155","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"American Heart Association. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.vph.2026.107612_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102388","article-title":"SGLT2 inhibitors in heart failure with preserved ejection fraction","volume":"49","author":"Faluk","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"issue":"12","key":"10.1016\/j.vph.2026.107612_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2025.103171","article-title":"Knowledge mapping of SGLT2-inhibitors and cardiovascular outcomes: a bibliometric analysis","volume":"50","author":"Rezabakhsh","year":"2025","journal-title":"Curr. Probl. Cardiol."},{"issue":"5","key":"10.1016\/j.vph.2026.107612_bb0170","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/CRD.0000000000000632","article-title":"Beyond glycemic control: Mechanistic insights into SGLT-2 inhibitors in heart failure management","volume":"33","author":"Garg","year":"2025","journal-title":"Cardiol. Rev."},{"issue":"3","key":"10.1016\/j.vph.2026.107612_bb0175","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/ehf2.13313","article-title":"SGLT2i versus ARNI in heart failure with reduced ejection fraction: a systematic review and meta-analysis","volume":"8","author":"Yan","year":"2021","journal-title":"ESC Heart Fail."},{"issue":"3","key":"10.1016\/j.vph.2026.107612_bb0180","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ejhf.1751","article-title":"Survival rates in elderly patients with heart failure: reply","volume":"22","author":"Jones","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.vph.2026.107612_bb0185","article-title":"Vulnerable period in heart failure: A window of opportunity for the optimization of treatment - a statement by Mexican experts","volume":"13","author":"Serrano","year":"2024","journal-title":"Drugs Context"},{"issue":"6","key":"10.1016\/j.vph.2026.107612_bb0190","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10741-019-09894-y","article-title":"Acutely decompensated versus acute heart failure: two different entities","volume":"25","author":"Xanthopoulos","year":"2020","journal-title":"Heart Fail. Rev."},{"issue":"10","key":"10.1016\/j.vph.2026.107612_bb0195","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1161\/CIRCRESAHA.121.318186","article-title":"Pathophysiology and therapeutic approaches to acute decompensated heart failure","volume":"128","author":"Njoroge","year":"2021","journal-title":"Circ. Res."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189126000327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189126000327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:33:20Z","timestamp":1786995200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189126000327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"alternative-id":["S1537189126000327"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2026.107612","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and five-year outcomes in a prospective Russian real-world heart failure cohort","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2026.107612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107612"}}